We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Sciex

SCIEX develops and sells scientific instrumentation, software, and services for the life science, clinical research, ... read more Featured Products: More products

Download Mobile App




Blood Test May Help Predict Confusion Post-Surgery

By LabMedica International staff writers
Posted on 09 Feb 2017
Print article
Image: The Triple Time-Of-Flight 5600 Mass Spectrometer (Photo courtesy of Sciex).
Image: The Triple Time-Of-Flight 5600 Mass Spectrometer (Photo courtesy of Sciex).
Many people experience an extended period of confusion when they awake after surgery and this acute confusional state, called delirium, particularly affects older adults and poses an important clinical challenge as it can lead to greater postoperative complications and may extend hospitalization.

Several biological models of delirium have been proposed and these include neuroinflammation, neurological aging, neuroendocrine stress, neurotransmitter dysregulation, oxidative stress, sleep/wake dysregulation, and network disconnectivity. The identification of a marker associated with delirium would advance our understanding of the pathophysiology of delirium and ultimately lead to new interventions that could improve patient outcomes.

Medial scientists at the Beth Israel Deaconess Medical Center enrolled 566 patients equal to or greater than 70 years old who were scheduled for major non-cardiac surgery, including total hip or knee replacement, cervical or lumbar laminectomy, abdominal aortic aneurysm repair, lower extremity vascular bypass, or colectomy. Patients received either general or spinal anesthesia. Blood samples were drawn at four time points before and after surgery from relatively healthy older adults who were undergoing major elective surgery.

The initial proteomics phase used isobaric tags for relative and absolute quantitation mass spectrometry assay to examine five sets of matched case-control plasma samples across the four time points in the discovery cohort. Relative quantitation proteomics was performed using the iTRAQ isobaric tagging system. In the biomarker validation stage, an antibody-based enzyme-linked immunosorbent assay (ELISA) was employed.

The scientists used a global proteomics approach to compare all proteins in the blood from a subset of the patients, C-reactive protein (CRP) emerged with the strongest association to postoperative delirium. In a discovery cohort of 39 matched cases, control pairs revealed that cases had higher CRP levels before the surgery and two days after, when delirium peaks. In a replication cohort of 36 different matched pairs, cases had higher CRP levels immediately after surgery and two days later.

Sarinnapha Vasunilashorn, PhD, co-first author of the study, said, “Our ability to pinpoint CRP levels as being significantly elevated before and after postoperative delirium onset establishes CRP as a risk marker, as well as a disease marker, for delirium. The findings also provide insight into what causes delirium and what puts someone at risk.” The study was published on January 15, 2017, in the journal Biological Psychiatry.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.